CoChat
Sign Up
Cited by 175BRCA gene mutations in cancerWomen's cancer prevention and managementFamily Support in Illness

The DOI matches its Crossref record; 33 of the 33 references it cites were found in a registry or an index.

One Year Follow-Up of Women Opting for Presymptomatic Testing for BRCA1 and BRCA2: Emotional Impact of the Test Outcome and Decisions on Risk Management (Surveillance or Prophylactic Surgery)

Lodder, Litanja N, Frets, Petra G, Trijsburg, R Willem, Meijers-Heijboer, E Johanna, Klijn, Jan GM, Seynaeve, Caroline, van Geel, Albertus N, Tilanus, Madeleine MA, Bartels, Carina CM, Verhoog, Leon C, Brekelmans, Cecile TM, Burger, Curt W, Niermeijer, Martinus F·2002·Breast Cancer Research and Treatment
DOI 10.1023/a:1015269620265
Open this paper in CoChat — free account

Abstract

Genetic testing enables women at risk for hereditary breast and/or ovarian cancer to find out whether they have inherited the gene mutation (BRCA1/BRCA2), and if so, to opt for frequent surveillance and/or prophylactic surgery (bilateral mastectomy and/or oophorectomy). Here, a follow-up is described for 63 healthy women at 50% risk of being a BRCA1/BRCA2 mutation carrier who underwent genetic testing. The course of distress and problems regarding body image and sexuality up to 1 year after disclosure of the test-outcome were described separately for mutation carriers undergoing mastectomy (n = 14), for mutation carriers opting for surveillance (n = 12) and for non-mutation carriers (n = 37). Furthermore, we analyzed whether women opting for prophylactic mastectomy differed from those opting for close surveillance with respect to biographical characteristics, experiences with cancer in relatives and personality. Women opting for prophylactic mastectomy had significantly higher distress levels than mutation carriers who opted for surveillance, and the non-mutation carriers. This difference in levels of distress was highest at pre- and post-test and had almost disappeared at 1-year follow-up. Besides, mutation carriers opting for prophylactic mastectomy were more often in their thirties, more often had young children and had a longer awareness of the genetic nature of cancer in the family than those opting for regular surveillance. Adverse effects were observed in women who underwent prophylactic mastectomy (mostly in combination with immediate breast reconstruction) regarding the perception of how their breast region looked like and felt, the intimate relationship and physical wellbeing whereas women opting for prophylactic mastectomy reported more distress than the other women in the study, their distress levels had significantly decreased 6 months or longer after surgery, possibly due to the significant risk reduction of developing breast cancer. This might explain, why most women who underwent prophylactic mastectomy were satisfied with this decision, despite a perceived negative impact on body image, the intimate relationship and physical wellbeing.

Overview

Integrity signals

Registry

Crossref · 10.1023/a:1015269620265

Cites

33 of 33 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Flagged first, then by citations

Show all 33 references

Research works printed but not linked: 2

  1. Lodder LN, Frets PG, Trijsburg RW, Meijers-Heijboer EJ, Klijn JGM, Duivenvoorden HJ: Presymptomatic testing for BRCA1 and BRCA2: How distressing are the pre-test weeks? J Med Gen 36: 906–913, 1999
  2. Arrindell WA, Ettema H: dimensional structure, reliability and validity of the Dutch version of the Symptom Checklist (SCL-90): data based on a phobic and a 'normal' population. Nederlands Tijdschrift voor de Psychologie en Haar Grensgebieden 36: 77–108, 1981

Cited by

Sorted by citations

See all 175

Related

See all

Metadata

Authors
Lodder, L. N., Frets, P. G., Trijsburg, R. W., Meijers-Heijboer, E. J., Klijn, J. G., Seynaeve, C., van Geel, A. N., Tilanus, M. M., Bartels, C. C., Verhoog, L. C., Brekelmans, C. T., Burger, C. W., & Niermeijer, M. F.
Affiliations
  • Erasmus University Rotterdam (NL)
  • Academisch Ziekenhuis Rotterdam (NL)
  • Erasmus MC (NL)
ORCID
Burger, Curt W
Venue
Breast Cancer Research and Treatment
Publisher
Springer Science and Business Media LLC
Published
2002-05
Volume
73
Issue
2
Pages
97-112
ISSN
  • 0167-6806 (ISSN-L)
  • 1573-7217
DOI
10.1023/a:1015269620265
OpenAlex
W1994789648
Cited by
175
References
33
Citations by year
2025: 1 · 2024: 3 · 2023: 4 · 2022: 3 · 2021: 3 · 2020: 4 · 2019: 6 · 2018: 5 · 2017: 4 · 2016: 9 · 2015: 3 · 2014: 7 · 2013: 7 · 2012: 10
FWCI
5.48
Type
journal article
Language
en
Open access
closed
Licence
Locations
  • Breast Cancer Research and Treatment (publishedVersion)
  • PubMed (publishedVersion)
  • Pure Amsterdam UMC (publishedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (publishedVersion)
  • Data Archiving and Networked Services (DANS) (submittedVersion)
  • EUR Research Repository (Erasmus University Rotterdam) (submittedVersion)
  • Radboud Repository (Radboud University) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Women's cancer prevention and management
  • Social Sciences › Psychology › Clinical Psychology › Family Support in Illness
Keywords
BRCA1, BRCA2, presymptomatic genetic testing, hereditary breast and ovarian cancer, prophylactic mastectomy, oophorectomy, cancer surveillance, psychological distress, body image, sexuality, intimate relationships, breast reconstruction, risk management decisions, disclosure of test results
MeSH terms
Adult, Body Image, Breast Neoplasms, Choice Behavior, Female, Follow-Up Studies, Heterozygote, Genetic Carrier Screening, Humans, Mastectomy, Middle Aged, Population Surveillance, Risk Factors, Risk Management, Patient Satisfaction, Genes, BRCA1, Genes, BRCA2, Risk Reduction Behavior

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review